Literature DB >> 11888873

Pure mucinous carcinoma of the breast: is axillary staging necessary?

Juan C Paramo1, Christopher Wilson, Diego Velarde, Jaime Giraldo, Robert J Poppiti, Thomas W Mesko.   

Abstract

BACKGROUND: Mucinous carcinoma of the breast (MCB) may be associated with a low risk of axillary metastases.
METHODS: To evaluate the incidence of axillary nodal metastasis in MCB, a review of all cases from January 1990 to July 2000 was performed. Pure MCB was defined as all tumor cells being completely surrounded by mucin. Patient demographics, tumor size, estrogen receptor status, total number of dissected lymph nodes, and incidence of nodal metastasis were studied. Deeper sections on the lymph nodes from the pure tumors were performed and stained with low-molecular cytokeratin.
RESULTS: Nineteen cases of pure MCB and 41 cases of mixed MCB were identified. Patients with pure MCB were older than those with mixed MCB. Tumor size and estrogen receptor status showed no statistically significant differences between the two groups. None of the patients with pure MCB demonstrated lymph node metastases, whereas 12 of 41 cases with mixed MCB demonstrated metastatic lymph node involvement.
CONCLUSIONS: Because pure MCB seems unlikely to metastasize, axillary lymph node staging in these patients may not be necessary. The presence of lymph node metastases strongly indicates the presence of a mixed MCB.

Entities:  

Mesh:

Year:  2002        PMID: 11888873     DOI: 10.1007/bf02557368

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  15 in total

1.  Pure mucinous breast carcinoma: a favorable subtype.

Authors:  Meng Yang; Xin Li; Pang Chun-Hong; Huang Lin-Ping
Journal:  Breast Care (Basel)       Date:  2013-03       Impact factor: 2.860

2.  Palliative surgery for giant mucinous carcinoma of the breast in an elderly patient: A rare case report.

Authors:  Haruko Takuwa; Wakako Tsuji; Fumiaki Yotsumoto
Journal:  Mol Clin Oncol       Date:  2017-08-21

3.  Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features.

Authors:  Purevsuren Jambal; Melanie M Badtke; J Chuck Harrell; Virginia F Borges; Miriam D Post; Grace E Sollender; Monique A Spillman; Kathryn B Horwitz; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2012-12-18       Impact factor: 4.872

4.  Clinicopathological characteristics and prognosis of mucinous breast carcinoma.

Authors:  Ming Zhang; Xiao-Dan Teng; Xin-Xin Guo; Ji-Shuang Zhao; Zhi-Gao Li
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-05       Impact factor: 4.553

5.  The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.

Authors:  Xingtong Zhou; Zhibo Zheng; Yan Li; Weiwei Zhao; Yan Lin; Jieshi Zhang; Qiang Sun
Journal:  BMC Cancer       Date:  2021-05-11       Impact factor: 4.430

6.  Mucinous carcinoma in a male breast.

Authors:  Roopak Aggarwal; Geetika Khanna; Shaham Beg
Journal:  J Cytol       Date:  2011-04       Impact factor: 1.000

7.  Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristics and prognosis.

Authors:  Soo Youn Bae; Min-Young Choi; Dong Hui Cho; Jeong Eon Lee; Seok Jin Nam; Jung-Hyun Yang
Journal:  J Breast Cancer       Date:  2011-12-27       Impact factor: 3.588

8.  Mucinous carcinoma with axillary lymph node metastasis in a male breast: A case report.

Authors:  Faten Hammedi; Amel Trabelsi; Soumaya Ben Abdelkrim; Lilia Ben Yacoub Abid; Wafa Jomaa; Ahlem Bdioui; Nadia Beizig; Moncef Mokni
Journal:  N Am J Med Sci       Date:  2010-02

9.  Mucinous carcinoma occurring in the male breast.

Authors:  Mitsuaki Ishida; Tomoko Umeda; Yuki Kawai; Tsuyoshi Mori; Yoshihiro Kubota; Hajime Abe; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Tohru Tani; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2013-12-05       Impact factor: 2.967

10.  Atypical breasts cancers.

Authors:  Lucie Wright; Cho Ee Ng; Tarannum Fasih
Journal:  Int J Surg Case Rep       Date:  2016-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.